Advertisement
Screener

BIOCANCELL THERAPEUTICS INC. Operating Income

BIOCANCELL THERAPEUTICS INC. Operating Income

BIOCANCELL THERAPEUTICS INC. reported Operating Income of -$1.20 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-10.

Discontinued › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2012-05-10

  • BIOCANCELL THERAPEUTICS INC. operating income (loss) for the quarter ending 2012-03-31 was -$1.20M.
  • BIOCANCELL THERAPEUTICS INC. operating income (loss) for the quarter ending 2011-12-31 was -$1.76M.
  • BIOCANCELL THERAPEUTICS INC. operating income (loss) for the quarter ending 2011-09-30 was -$1.36M.
  • BIOCANCELL THERAPEUTICS INC. operating income (loss) for the quarter ending 2011-06-30 was -$1.38M.
  • BIOCANCELL THERAPEUTICS INC. operating income (loss) for fiscal 2011 was -$5.64M.
  • BIOCANCELL THERAPEUTICS INC. operating income (loss) for fiscal 2010 was -$3.77M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 6 monthOperating Income (Loss) 9 monthOperating Income (Loss) 12 monthOperating Income (Loss) 81 monthOperating Income (Loss) 84 monthOperating Income (Loss) 87 monthOperating Income (Loss) 90 month
2012-03-31-$1.20M
10-Q · filed 2012-05-10
-$2.96M
derived: sum of 2 quarters · filed 2012-05-10
-$4.32M
derived: sum of 3 quarters · filed 2012-05-10
-$5.70M
derived: sum of 4 quarters · filed 2012-05-10
-$26.16M
10-Q · filed 2012-05-10
2011-12-31-$1.76M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30
-$3.13M
derived: sum of 2 quarters · filed 2012-03-30
-$4.50M
derived: sum of 3 quarters · filed 2012-03-30
-$5.64M
10-K · filed 2012-03-30
-$24.96M
10-K · filed 2012-03-30
2011-09-30-$1.36M
10-Q · filed 2011-11-07
-$2.74M
derived: sum of 2 quarters · filed 2011-11-07
-$3.88M
10-Q · filed 2011-11-07
-$5.36M
derived: sum of 4 quarters · filed 2012-05-10
-$23.20M
10-Q · filed 2011-11-07
2011-06-30-$1.38M
10-Q/A · filed 2011-08-30
-$2.52M
10-Q/A · filed 2011-08-30
-$4.00M
derived: sum of 3 quarters · filed 2012-05-10
-$4.61M
derived: sum of 4 quarters · filed 2012-05-10
-$21.84M
10-Q/A · filed 2011-08-30
2011-03-31-$1.14M
10-Q · filed 2012-05-10
-$2.63M
derived: sum of 2 quarters · filed 2012-05-10
-$3.23M
derived: sum of 3 quarters · filed 2012-05-10
-$3.98M
derived: sum of 4 quarters · filed 2012-05-10
2010-12-31-$1.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30
-$2.09M
derived: sum of 2 quarters · filed 2012-03-30
-$2.84M
derived: sum of 3 quarters · filed 2012-03-30
-$3.77M
10-K · filed 2012-03-30
2010-09-30-$604.00K
10-Q · filed 2011-11-07
-$1.35M
derived: sum of 2 quarters · filed 2011-11-07
-$2.29M
10-Q · filed 2011-11-07
2010-06-30-$751.00K
10-Q/A · filed 2011-08-30
-$1.68M
10-Q/A · filed 2011-08-30